Pharmacology & Toxicology 1994-08-01

Effect of toluene inhalation on extracellular striatal acetylcholine release studied with microdialysis.

K Stengård

Index: Pharmacol. Toxicol. 75(2) , 115-8, (1994)

Full Text: HTML

Abstract

Intracerebral microdialysis was performed on awake, freely moving rats in order to record effect of toluene exposure on acetylcholine release in striatum. Acetylcholine release decreased during (about 20%) and after (about 60%) toluene exposure (2 hr, 2000 p.p.m.) Striatal acetylcholine release is thought to be mediated by dopamine. In a previous work we found that extracellular dopamine levels increase during toluene exposure. A dopamine uptake inhibitor (LU 19-005, 2 mg/kg) was therefore injected subcutaneously and the effect of increased extracellular dopamine on acetylcholine release within the striatum was monitored in the absence of toluene exposure. LU 19-005 increased striatal dopamine levels six times and the acetylcholine levels increased to about 145% of basal value. The present study shows that toluene exposure decrease acetylcholine release while an injection of a dopamine uptake inhibitor fails to decrease acetylcholine release. Indicating that acute exposure of toluene decreases striatal acetylcholine release by a mechanism that is not mediated by increased extracellular dopamine levels. Our data suggest that toluene decrease acetylcholine release within the striatum and that this effect not is mediated by increased extracellular dopamine levels.


Related Compounds

  • Indatraline hydroc...

Related Articles:

Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys.

1999-10-01

[J. Pharmacol. Exp. Ther. 291 , 60-69, (1999)]

Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin.

1985-05-01

[J. Neurochem. 44 , 1615-1622, (1985)]

Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.

1985-04-01

[Naunyn Schmiedebergs Arch. Pharmacol. 329 , 101-107, (1985)]

Down-regulation of dopamine D-2, 5-HT2 receptors and beta-adrenoceptors in rat brain after prolonged treatment with a new potential antidepressant, Lu 19-005.

[J. Neural Transm. Gen. Sect. 64 , 227-238, (1985)]

In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen.

1989-07-18

[Eur. J. Pharmacol. 166(2) , 251-60, (1989)]

More Articles...